Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CNCE
FechaHoraFuenteTítuloSímboloCompañía
03/03/202206:09Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/03/202205:09Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/03/202205:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/03/202205:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
03/03/202205:00Business WireConcert Pharmaceuticals Reports 2021 Financial Results and Provides Company UpdateNASDAQ:CNCEConcert Pharmaceuticals Inc
24/02/202206:00Business WireConcert Pharmaceuticals to Report Fourth Quarter 2021 Results on March 3, 2022NASDAQ:CNCEConcert Pharmaceuticals Inc
16/02/202207:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202215:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202221:25TipRanksBerenberg Bank Thinks Concert Pharma’s Stock is Going to RecoverNASDAQ:CNCEConcert Pharmaceuticals Inc
04/01/202206:00Business WireConcert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
03/01/202206:00Business WireConcert Pharmaceuticals to Present at H.C. Wainwright BIOCONNECT Virtual ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
15/11/202116:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
11/11/202106:00Business WireConcert Pharmaceuticals to Participate in Fireside Chat at Jefferies London Healthcare ConferencesNASDAQ:CNCEConcert Pharmaceuticals Inc
09/11/202106:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNCEConcert Pharmaceuticals Inc
09/11/202106:00Business WireConcert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company UpdateNASDAQ:CNCEConcert Pharmaceuticals Inc
05/11/202112:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CNCEConcert Pharmaceuticals Inc
04/11/202106:00Business WireConcert Pharmaceuticals Announces $65 Million FinancingNASDAQ:CNCEConcert Pharmaceuticals Inc
02/11/202106:00Business WireConcert Pharmaceuticals to Report Third Quarter 2021 Results on November 9, 2021NASDAQ:CNCEConcert Pharmaceuticals Inc
25/10/202106:00Business WireConcert Pharmaceuticals Completes Enrollment in THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
03/09/202106:00Business WireConcert Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:CNCEConcert Pharmaceuticals Inc
31/08/202106:00Business WireLandmarks and Bridges Will Illuminate Blue Throughout the Month of September for Alopecia Areata Awareness MonthNASDAQ:CNCEConcert Pharmaceuticals Inc
05/08/202106:00Business WireConcert Pharmaceuticals Reports Second Quarter 2021 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
29/07/202106:00Business WireConcert Pharmaceuticals to Report Second Quarter 2021 Results on August 5, 2021NASDAQ:CNCEConcert Pharmaceuticals Inc
01/07/202106:00Business WireConcert Pharmaceuticals Presents Update on CTP-543 Long-Term Extension Study in Alopecia Areata During 2nd JAK Inhibitors Dru...NASDAQ:CNCEConcert Pharmaceuticals Inc
27/05/202106:00Business WireConcert Pharmaceuticals Initiates THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
17/05/202115:01Business WireConcert Pharmaceuticals Announces Sale of VX-561 Milestones to Vertex for $32 MillionNASDAQ:CNCEConcert Pharmaceuticals Inc
04/05/202106:00Business WireConcert Pharmaceuticals Reports First Quarter 2021 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
27/04/202106:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CNCEConcert Pharmaceuticals Inc
27/04/202106:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CNCEConcert Pharmaceuticals Inc
27/04/202106:00Business WireConcert Pharmaceuticals to Report First Quarter 2021 Results on May 4, 2021NASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE